Age (years)
|
|
< 65 |
201 (72.0%) |
≥ 65 |
78 (28.0%) |
Sex
|
|
Men |
249 (89.2%) |
Women |
30 (10.8%) |
Site of the primary tumor
|
|
Tongue |
113 (40.5%) |
Buccal mucosa |
85 (30.5%) |
Gingiva |
34 (12.2%) |
Retromolar trigone |
18 (6.5%) |
Mouth floor |
13 (4.7%) |
Lip |
11 (3.9%) |
Hard palate |
5 (1.7%) |
AJCC stage
|
|
I |
52 (18.6%) |
II |
38 (13.6%) |
III |
45 (16.1%) |
IV |
144 (51.7%) |
Tumor size (T classification)
|
|
T1 |
70 (25.1%) |
T2 |
52 (18.6%) |
T3 |
44 (15.8%) |
T4 |
113 (40.5%) |
Nodal metastasis (N classification)
|
|
N0 |
179 (64.2%) |
N1 |
30 (10.8%) |
N2 |
55 (19.7%) |
N3 |
15 (5.3%) |
PNI
|
70 (25.1%) |
ENE
|
55 (19.7%) |
Cancer cell differentiation
|
|
W-D/M-D |
248 (88.9%) |
P-D |
31 (11.1%) |
Surgical margin
|
|
≥ 5 mm |
206 (73.8%) |
< 5 mm |
73 (26.2%) |
DOI ≥ 10 mm
|
133 (47.7%) |
CCI
|
|
0 |
145 (52.0%) |
1 |
82 (29.4%) |
≥ 2 |
52 (18.6%) |
Personal Habits
|
|
Cigarette Smoking |
231 (82.8%) |
Betel nut chewing |
222 (79.6%) |
Alcohol consumption |
187 (67.0%) |
Treatment
|
|
Surgery only |
134 (48.0%) |
Surgery + RT |
39 (14.0%) |
Surgery + CRT |
106 (38.0%) |
Laboratory results
|
|
WBC (X103/μL), median (IQR) |
7.70 (6.30-9.70) |
Neutrophil (X103/μL), median (IQR) |
4.80 (3.59-6.44) |
Lymphocyte (X103/μL), median (IQR) |
2.01 (1.58-2.59) |
CRP (mg/dL), median (IQR) |
0.36 (0.13-1.52) |
Albumin (g/dL), median (IQR) |
4.43 (4.10-4.68) |
CALLY index, median (IQR) |
2.51 (0.52-7.45) |